• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断和治疗膀胱尿路上皮癌。

Diagnosis and management of urothelial carcinoma of the bladder.

机构信息

Department of Medicine, Section of Medical Oncology, Baylor College of Medicine, Houston, TX, USA.

出版信息

Postgrad Med. 2011 May;123(3):43-55. doi: 10.3810/pgm.2011.05.2283.

DOI:10.3810/pgm.2011.05.2283
PMID:21566415
Abstract

Bladder carcinoma is the fourth most common cancer in men and the ninth most common cancer in women in the United States. In 2010, approximately 70,000 new cases of bladder carcinoma (52,000 in men and 18000 in women) and approximately 14000 deaths were expected in the United States. More than 90% of bladder carcinomas are classified as urothelial carcinoma (UC), which arise from the urothelium. This epithelium, also known as transitional cell epithelium, lines the urinary tract, which extends from the renal pelvis through the ureters, bladder, and urethra. Urothelial carcinoma of the bladder may present as a non-muscle-invasive, muscle-invasive, or metastatic malignancy. In noninvasive tumors, treatment by cystoscopic resection and intravesical therapy is directed at reducing recurrences and preventing progression to a more advanced stage. The goal in invasive tumors is a combination of radical cystectomy and perioperative cisplatin-based combination chemotherapy to enhance outcomes by reducing the high risk of distant recurrences. Outcomes in metastatic UC are dismal with current cisplatin-based combination chemotherapy, and progressive disease after frontline chemotherapy is characterized by a short survival. Therefore, clinical trials should be the focus for metastatic UC. It is important for primary care physicians to recognize the early signs and symptoms of bladder carcinoma, initiate the proper work-up, and refer promptly to a urologist to evaluate suspicious signs and symptoms.

摘要

膀胱癌是美国男性中第四大常见癌症,女性中第九大常见癌症。2010 年,预计美国将有大约 70000 例膀胱癌新病例(男性 52000 例,女性 18000 例)和大约 14000 例死亡病例。超过 90%的膀胱癌被归类为尿路上皮癌(UC),它起源于尿路上皮。这种上皮组织,也称为移行细胞上皮,覆盖着泌尿道,从肾盂延伸到输尿管、膀胱和尿道。膀胱尿路上皮癌可表现为非肌肉浸润性、肌肉浸润性或转移性恶性肿瘤。在非浸润性肿瘤中,通过膀胱镜切除和膀胱内治疗来治疗,旨在减少复发并防止进展为更高级别。侵袭性肿瘤的目标是结合根治性膀胱切除术和围手术期顺铂为基础的联合化疗,通过降低远处复发的高风险来提高疗效。转移性 UC 的治疗结果较差,目前基于顺铂的联合化疗效果不佳,一线化疗后疾病进展的特点是生存期短。因此,临床试验应是转移性 UC 的重点。初级保健医生识别膀胱癌的早期体征和症状,进行适当的检查,并迅速转介给泌尿科医生评估可疑的体征和症状,这一点非常重要。

相似文献

1
Diagnosis and management of urothelial carcinoma of the bladder.诊断和治疗膀胱尿路上皮癌。
Postgrad Med. 2011 May;123(3):43-55. doi: 10.3810/pgm.2011.05.2283.
2
Diagnosis and treatment of bladder cancer.膀胱癌的诊断与治疗。
Am Fam Physician. 2009 Oct 1;80(7):717-23.
3
Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma.浸润性尿路上皮膀胱癌选择性部分膀胱切除术的长期结果
Urology. 2008 Sep;72(3):613-6. doi: 10.1016/j.urology.2008.04.052. Epub 2008 Jun 13.
4
Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.膀胱移行细胞癌根治性膀胱切除术后上尿路尿路上皮复发:1069例患者10年随访分析
J Urol. 2007 Jun;177(6):2088-94. doi: 10.1016/j.juro.2007.01.133.
5
Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.膀胱非肌层浸润性尿路上皮细胞癌患者中Survivin的表达
Urology. 2007 Sep;70(3):482-6. doi: 10.1016/j.urology.2007.05.009.
6
The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.复发性高危浅表性膀胱肿瘤患者根治性膀胱切除术的最佳时机。
BJU Int. 2004 Dec;94(9):1258-62. doi: 10.1111/j.1464-410X.2004.05228.x.
7
Bladder cancer.膀胱癌
Curr Opin Oncol. 2006 May;18(3):277-83. doi: 10.1097/01.cco.0000219258.75961.1a.
8
Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors.膀胱肌层浸润性尿路上皮癌中Her-2/neu过表达:原发性和转移性肿瘤的预后意义及比较分析
Clin Cancer Res. 2001 Aug;7(8):2440-7.
9
Behavior of urothelial carcinoma with respect to anatomical location.尿路上皮癌在解剖学位置方面的表现。
J Urol. 2007 May;177(5):1715-20. doi: 10.1016/j.juro.2007.01.030.
10
Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.息肉样/乳头状膀胱炎:41例被误诊为乳头状尿路上皮肿瘤的病例系列
Am J Surg Pathol. 2008 May;32(5):758-64. doi: 10.1097/PAS.0b013e31816092b5.

引用本文的文献

1
2'-Hydroxyflavanone inhibits bladder cancer cell proliferation and angiogenesis via regulating miR-99a-5p/mTOR signaling.2'-羟基黄烷酮通过调节miR-99a-5p/mTOR信号通路抑制膀胱癌细胞增殖和血管生成。
Am J Clin Exp Urol. 2025 Feb 15;13(1):20-32. doi: 10.62347/CBAO9374. eCollection 2025.
2
Prognostic predictive value of urothelial carcinoma of the bladder after TURBT based on multiphase CT radiomics.基于多期CT影像组学的膀胱尿路上皮癌经尿道膀胱肿瘤电切术后的预后预测价值
Abdom Radiol (NY). 2024 Jun;49(6):1975-1986. doi: 10.1007/s00261-024-04265-0. Epub 2024 Apr 15.
3
Genomic Biomarker Discovery in Disease Progression and Therapy Response in Bladder Cancer Utilizing Machine Learning.
利用机器学习发现膀胱癌疾病进展和治疗反应中的基因组生物标志物
Cancers (Basel). 2023 Sep 29;15(19):4801. doi: 10.3390/cancers15194801.
4
Lymphangitic Carcinomatosis of Possible Urothelial Origin.可能起源于尿路上皮的淋巴管癌病
Cureus. 2023 Mar 11;15(3):e36030. doi: 10.7759/cureus.36030. eCollection 2023 Mar.
5
An Unexpected and Unpredictable Emergence of Muscle-Invasive Bladder Cancer in a Patient Successfully Treated With Nivolumab for Small-Cell Bladder Cancer.一名接受纳武单抗成功治疗小细胞膀胱癌的患者意外且不可预测地出现了肌层浸润性膀胱癌。
Cureus. 2022 Dec 6;14(12):e32244. doi: 10.7759/cureus.32244. eCollection 2022 Dec.
6
Primary Small Cell Carcinoma of the Bladder.膀胱原发性小细胞癌
Cureus. 2021 May 21;13(5):e15146. doi: 10.7759/cureus.15146.
7
A Rare Case of Sensory Neuropathy Associated with Transitional Cell Carcinoma of the Bladder.1例罕见的与膀胱移行细胞癌相关的感觉神经病变
Case Rep Oncol. 2020 Nov 30;13(3):1397-1401. doi: 10.1159/000510742. eCollection 2020 Sep-Dec.
8
Low Expression of hsa_circ_0018069 in Human Bladder Cancer and Its Clinical Significance.hsa_circ_0018069在人膀胱癌中的低表达及其临床意义
Biomed Res Int. 2019 Mar 10;2019:9681863. doi: 10.1155/2019/9681863. eCollection 2019.
9
Sarcomatoid urothelial carcinoma with chondrosarcomatous differentiation of the ureter: A case report and review of the literature.输尿管软骨肉瘤样分化的肉瘤样尿路上皮癌:一例报告并文献复习
Oncol Lett. 2017 Mar;13(3):1331-1337. doi: 10.3892/ol.2017.5575. Epub 2017 Jan 5.
10
Cancer/testis antigens and urological malignancies.癌症/睾丸抗原与泌尿系统恶性肿瘤。
Nat Rev Urol. 2012 Jun 19;9(7):386-96. doi: 10.1038/nrurol.2012.117.